CPC A61K 38/063 (2013.01) [A01N 1/0226 (2013.01); A61K 9/0031 (2013.01); A61K 9/0034 (2013.01); A61K 9/006 (2013.01); A61K 9/0073 (2013.01); A61K 9/0075 (2013.01); A61K 9/008 (2013.01); A61K 31/198 (2013.01); A61K 31/375 (2013.01); A61K 33/00 (2013.01); A61K 33/04 (2013.01); A61K 33/10 (2013.01); A61K 38/40 (2013.01); A61K 38/443 (2013.01); A61K 45/06 (2013.01); C12Y 101/03004 (2013.01); C12Y 111/01007 (2013.01); C12Y 302/01011 (2013.01); C12Y 302/01017 (2013.01); C12Y 302/01059 (2013.01)] | 36 Claims |
1. A method for reducing the onset and/or progression of bacterial growth in a subject's airway, comprising prophylactically administering by inhalation to the airway of the subject an effective amount of a composition comprising:
a) a glutathione, or a pharmaceutically-acceptable salt of glutathione;
b) an organic acid or a pharmaceutically-acceptable salt of an organic acid; and
c) a carrier,
wherein the subject suffers from a pulmonary or airway disorder or disease selected from the group consisting of an inflammatory lung disease and/or infection of the lung, inflammation and/or infection associated with lung transplantation, acute lung rejection, asthma, cystic fibrosis, chronic obstructive pulmonary disease (COPD), and any combination thereof.
|